Growth Hormone Deficiency
📧 Sign up to get email alerts when something new happens for Growth Hormone Deficiency.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: A Bioequivalence Study of Two Different Processes of PEG-rhGH Preparations [Phase 1]
This document reports a Phase 1 bioequivalence study comparing two production processes for PEG-rhGH and involves pediatric growth hormone d…
-
EMA approval · 2025-02-12EMA Authorised: Skytrofa (previously Lonapegsomatropin Ascendis Pharma) (Lonapegsomatropin) — Ascendis Pharma Endocrinology Division A/S
The European Medicines Agency authorised Skytrofa (lonapegsomatropin) from Ascendis Pharma Endocrinology Division A/S for growth hormone def…
-
FDA approval · 2025-01-31FDA Approved: SOGROYA — Supplemental Application (Novo Nordisk)
FDA approves a supplemental application for SOGROYA (somapacitan-beco) from Novo Nordisk.
-
FDA approval · 2025-01-31FDA Approved: NORDITROPIN — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for Norditropin (somatropin) from Novo Nordisk.
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency [Phase 3]
Phase 3 trial comparing once-weekly lonapegsomatropin with placebo and daily somatropin in adults with growth hormone deficiency has complet…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2024-12-18Clinical Trial Update: Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21)
This clinical trial investigating how growth hormone deficiency and growth hormone replacement affect serum FGF21 has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Assessment of Adherence, Quality of Life, Clinical Response and Safety of Daily and Long-Acting Growth Hormone Therapy
A clinical trial update reports on adherence, quality of life, clinical response, and safety for daily and long-acting growth hormone therap…
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: BELux Children OutcoME During A(@)Dulthood With GHD [NA]
Clinical trial update for a study on growth hormone deficiency tracking outcomes from childhood to adulthood; the trial is not yet recruitin…
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: A Bioequivalence Study of Two Different PEG-rhGH Preparations. [Phase 1]
Phase 1 bioequivalence study comparing two PEG-rhGH preparations for pediatric growth hormone deficiency.
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial) [Phase 2]
A Phase 2 trial evaluating LUM-201 for children with growth hormone deficiency has completed, providing the Phase 2 readout for the investig…
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Vesiculogenesis in Children With GH Deficiency (VESCIGHTP)
This clinical trial update notes that the Vesiculogenesis in Children With Growth Hormone Deficiency (VESCIGHTP) study is currently active b…
-
FDA label_change · 2024-08-16FDA Approved: GENOTROPIN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for Genotropin (somatropin) from Pfizer, resulting in changes to the labeling. The notice reflects t…
-
CLINICAL_TRIALS research · 2024-08-12Clinical Trial Update: A Research Study of How Well Macimorelin Works to Find Out if Children Have a Lack of Growth Hormone and How Safe it is [Phase 3]
Phase 3 clinical trial update evaluating macimorelin for diagnosing growth hormone deficiency in children; the study has completed.
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: Evaluation of the Propensity of Patients Under rhGH to Envision a Modification of Their Treatment Regimen Toward LAGH [NA]
This clinical trial update notes ongoing recruitment for a study examining whether patients on recombinant human growth hormone with Growth …
-
CLINICAL_TRIALS trial_result · 2024-07-17Clinical Trial Update: Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk Factors [Phase 1, Phase 2]
This Phase 1/2 trial compares the effects of recombinant human growth hormone (somatropin) versus recombinant human IGF-1 (mecasermin) on ca…
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: PREPL in Health and Disease [NA]
Clinical trial update indicates PREPL-related studies at KU Leuven are currently active but not recruiting, exploring PREPL's role in Hypoto…
-
FDA approval · 2024-07-05FDA Approved: NGENLA — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for NGENLA (somatrogon-ghla) from Pfizer Laboratories Div Pfizer Inc.
-
CLINICAL_TRIALS research · 2024-06-13Clinical Trial Update: Use of miRNAs in Growth Hormone Deficiency (GHD)
A clinical trial update indicates ongoing recruitment for a study exploring microRNA-based approaches to Growth Hormone Deficiency.
-
EMA approval · 2024-05-13EMA Authorised: Ghryvelin (previously Macimorelin Aeterna Zentaris) (macimorelin acetate) — Atnahs Pharma Netherlands B.V.
The European Medicines Agency authorised Ghryvelin (macimorelin acetate) by Atnahs Pharma Netherlands B.V. as a new diagnostic drug for grow…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial [Phase 3]
A long-term Phase 3 trial evaluating the safety and efficacy of TransCon hGH in children with growth hormone deficiency who completed a prio…
-
CLINICAL_TRIALS trial_result · 2024-04-15Clinical Trial Update: A Study to Evaluating the Efficacy and Safety of Recombinant Long-acting Human Growth Hormone (TJ101) in Children With Growth Hormone Deficiency [Phase 3]
Phase 3 trial evaluating the efficacy and safety of recombinant long-acting human growth hormone (TJ101) in children with growth hormone def…
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients [Phase 4]
Phase 4 clinical trial evaluating the effect of somatropin on left ventricular mass in adults with growth hormone deficiency has completed.
-
CLINICAL_TRIALS trial_result · 2024-02-15Clinical Trial Update: A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial (OraGrowtH211) [Phase 2]
A long-term safety trial evaluating LUM-201 in children with idiopathic growth hormone deficiency who previously completed a LUM-201 trial (…
-
CLINICAL_TRIALS trial_result · 2024-01-24Clinical Trial Update: Safety and Efficacy of Y-shape Pegylated Somatropin in Growth Hormone Deficiency Children [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial evaluating safety and efficacy of a Y-shape pegylated somatropin in children with growth hormone defici…
-
FDA approval · 2023-12-27FDA Approved: NGENLA — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for NGENLA (somatrogon-ghla) submitted by Pfizer Laboratories Div Pfizer Inc, indicating an appr…